Home › Blog › Weight Loss › Mounjaro Dosing Schedule

Mounjaro Dosing Schedule UK 2026: Every Dose From 2.5mg to 15mg — When to Escalate, When to Stay, and What to Expect

Overview: The Mounjaro Dosing Schedule

Mounjaro (tirzepatide) is a once-weekly injection given in six escalating doses — from 2.5mg (initiation) to 15mg (maximum maintenance). The dose escalation protocol is not arbitrary: it exists because starting at higher doses produces significantly worse gastrointestinal side effects. Gradual escalation allows the body to adapt to tirzepatide’s GLP-1 and GIP receptor activation before each increase.

Understanding the schedule — what each dose does, when to move to the next, and when to stay longer — is one of the most important things any Mounjaro patient can know. At Slinic, every dose escalation is reviewed by a registered prescriber before being approved. This guide explains what that review considers and how to get the most from every stage of your treatment.

The Complete Mounjaro Dosing Schedule

All Slinic prices + £4.99 delivery. No subscription. Free monthly check-ins. Subject to clinician approval at each stage.

Dose-by-Dose: What to Expect at Every Stage

When to Escalate and When to Stay Longer

The standard protocol escalates by one dose every 4 weeks. But this is a minimum, not a mandate. Here is the clinical framework Slinic uses to determine whether to escalate on schedule or stay at a dose longer.

Missing a Dose: What to Do

Injection Technique: How to Use the Mounjaro KwikPen

1. Remove from fridge 30 minutes before — allow to reach room temperature. Cold medication causes more discomfort.
2. Choose your injection site — abdomen (at least 2 inches from navel), outer thigh, or upper arm. Rotate each week — never the same spot twice consecutively.
3. Clean the site — alcohol wipe, allow to dry.
4. Attach the pen needle — needles are not pre-attached. Use a new needle for every injection.
5. Remove the cap — outer cap first, then inner cap.
6. Pinch the skin gently — hold the pen at 90 degrees to the skin.
7. Press and hold for 10 seconds — press the button firmly. Hold for a full 10 seconds to ensure complete dose delivery.
8. Dispose of needle immediately — in your sharps bin. Never re-use needles.

Mounjaro Storage: The Complete Guide

Do not freeze Mounjaro. Do not use a pen that has been frozen. Do not use a pen past its expiry date. Slinic delivers all Mounjaro in certified cold-chain packaging maintaining 2–8°C throughout transit.

Finding Your Optimal Maintenance Dose

One of the most important — and underappreciated — aspects of Mounjaro treatment is that the right maintenance dose is not necessarily 15mg. Here is the clinical framework for finding your personal optimal dose.

You may not need 15mg if:

• You are achieving consistent, ongoing weight loss at 10mg or 12.5mg
• You have already reached or are close to your weight goal
• Side effects at 12.5mg were more significant than at 10mg
• Your Slinic clinician assesses that your results at the current dose are clinically satisfactory

You should escalate to 15mg if:

• Weight loss has clearly plateaued at your current dose
• You have not yet achieved 15% of starting body weight lost after 6 months on 12.5mg
• Your Slinic clinician assesses that you are tolerating the current dose well and would benefit from further escalation

Mounjaro Dosing for Type 2 Diabetes

Mounjaro is also licensed for type 2 diabetes management in the UK. The dosing schedule for T2D is the same as for weight management — starting at 2.5mg and escalating by 2.5mg every 4 weeks to a maximum of 15mg. The key difference for T2D patients is that blood sugar may improve rapidly, requiring dose adjustments to insulin or sulphonylureas to prevent hypoglycaemia. Coordinate with your diabetes team or GP throughout escalation if you are on insulin or sulphonylureas.

Stopping Mounjaro: The Right Protocol

There are several situations where Mounjaro should be stopped, temporarily paused, or dose-reduced. Here is the clinical framework:

Mounjaro Dosing vs Wegovy Dosing: Comparison

Week-by-Week Guide: Your First 24 Weeks on Mounjaro

Beyond the dose stages, here is a granular week-by-week guide to the first 24 weeks of Mounjaro treatment — what most patients experience, and what your Slinic clinician is monitoring at each point.

5 Common Dosing Mistakes and How to Avoid Them

Mistake 1: Stopping after one difficult week

The most common reason patients discontinue Mounjaro is experiencing side effects in the first week of a new dose and concluding the medication does not suit them. In the vast majority of cases, the side effects resolve within 7–10 days as the body adapts. Stopping at day 5 of 5mg after feeling nauseated is throwing away the entire investment in the 4 weeks on 2.5mg that preceded it. Contact your Slinic clinician about side effects before stopping — almost always a dose reduction or dietary adjustment resolves the issue.

Mistake 2: Escalating too quickly

Some patients, eager for faster results, request escalation before their 4-week minimum. Premature escalation significantly amplifies side effects and reduces adherence. The 4-week minimum is not bureaucratic — it reflects the physiological time needed for the body to adapt to GLP-1 receptor activation at each dose level. At Slinic, every escalation is reviewed by a registered prescriber who specifically checks that the minimum duration and tolerance criteria are met.

Mistake 3: Assuming maximum dose means maximum effort

Some patients feel that staying at 10mg or 12.5mg represents a failure or insufficient commitment to treatment. It does not. If you are losing weight consistently and tolerating the current dose well, that dose may be your optimal maintenance dose — producing results that, by any historical measure, are extraordinary. The goal is clinical outcomes, not reaching the highest number on the pen.

Mistake 4: Not rotating injection sites

Injecting in the same spot repeatedly causes lipohypertrophy — hardened fatty tissue under the skin that absorbs the medication less consistently, reducing efficacy and causing discomfort. Use a different location every week: cycle through the abdomen, both outer thighs, and both upper arms. Keep a simple rotation log if you find it easy to forget.

Mistake 5: Forgetting protein during dose escalation

Mounjaro suppresses appetite so effectively that many patients eat very little — but eat without deliberate attention to protein content. Rapid weight loss combined with low protein intake accelerates lean muscle loss, hair thinning, and fatigue. Every dose escalation should be accompanied by a conscious check: “Am I eating enough protein?” The target is 1.2–1.6g per kilogram of target body weight per day at all times during treatment.

When and How to Reduce Your Dose

Dose reduction is an underused and underappreciated tool in Mounjaro management. When side effects are unacceptable at a particular dose, reducing back to the previous dose is almost always preferable to stopping entirely.

How dose reduction works at Slinic

Contact your Slinic clinician — by message or phone between your monthly appointments if side effects are significant. We will review whether a dose reduction is appropriate, approve the reduction, and dispatch the lower-dose pen. A patient who successfully maintains at 7.5mg long-term is producing better clinical outcomes than a patient who stopped at 10mg because of unmanaged nausea.

Dose reduction does not reset your progress

Returning from 10mg to 7.5mg does not erase the weight lost on 10mg. The metabolic changes, reduced adiposity, and improved health markers that occurred at 10mg persist. The dose reduction simply means you are continuing treatment at the highest dose you can comfortably tolerate — which is the right clinical approach.

After You Reach Your Weight Goal: Maintenance Dosing

Reaching your target weight is a clinical milestone — but the conversation about what happens next should happen well before you reach it. Here is the clinical framework for long-term maintenance dosing.

Option 1: Continue at current maintenance dose

The most straightforward approach. SURMOUNT-4 data shows that continuing tirzepatide at the maximum tolerated dose maintains weight loss. Monthly check-ins continue. Cost is the primary consideration for long-term maintenance at higher doses.

Option 2: Reduce to a lower maintenance dose

Some patients find that a lower dose (e.g. 10mg rather than 15mg) is sufficient to maintain their weight once the initial loss is complete. Your Slinic clinician can guide a gradual reduction trial — monitoring weight stability at each lower dose before reducing further.

Option 3: Extend injection intervals

For some patients at maintenance, extending the injection interval from every 7 days to every 10–14 days may maintain weight stability. This is not a standard licensed approach and requires careful monitoring — discuss with your Slinic clinician.

Option 4: Gradual tapering and stopping

Patients who have established strong dietary and lifestyle habits during treatment may attempt gradual tapering — reducing dose and then interval over several months — to assess whether the habits alone can maintain weight. This is the most clinically ambitious approach and requires the closest monitoring. SURMOUNT-4 data shows that most patients who stop abruptly regain significant weight — tapering gives a better chance of sustainable maintenance.

Frequently Asked Questions

What to Eat (and Avoid) Around Injection Day

The relationship between your diet and your injection day significantly affects how you experience each dose. Here is the complete dietary protocol Slinic recommends around injection day.

Injection day and 48 hours after: the gentle protocol

• Eat very small meals — 4–5 times per day rather than 3 large meals
• Avoid all fried, greasy, and high-fat foods — these are the biggest nausea triggers
• Avoid alcohol entirely — particularly for the first 48 hours after each new dose
• Avoid spicy or very rich food — treat your stomach as sensitive for the first 48 hours
• Stay well hydrated — sip water, herbal tea, and diluted juice throughout the day
• Try injecting in the evening — many patients find that doing so means the peak nausea period (first 12–24 hours) occurs during sleep

Days 3–7: gradual return to normal eating

• Gradually introduce normal food as tolerance returns
• Continue with smaller portions than pre-Mounjaro — the medication is doing its job
• Prioritise protein at every meal — chicken, fish, eggs, legumes, dairy
• Include plenty of vegetables — both for nutrition and gut health

Days 7+ (at established dose): sustainable eating pattern

• Protein-first approach at every meal — fill half your plate with protein before adding carbohydrates
• Small, satisfying meals — the medication has reduced your capacity; honour that by eating until satisfied, not until full
• Avoid eating through nausea — if the medication is suppressing appetite, do not eat just because it is mealtime. Eat when hungry; stop when satisfied.
• Maintain adequate calories — aim for at least 1,200–1,400 calories per day minimum to prevent excessive lean mass loss

Exercise and Mounjaro: How Physical Activity Interacts With Your Dosing

Exercise does not need to be timed around Mounjaro injections specifically, but there are important interactions between physical activity and your dosing outcomes that are worth understanding.

Resistance training timing

There is no clinical reason to avoid exercise around injection day. However, if you experience significant nausea on injection day, high-intensity exercise may feel uncomfortable. Light walking is fine and often helpful for gut motility. Save heavier resistance training for days when you feel well — typically days 3–7 of each dose cycle.

Building resistance training into your treatment

The most clinically important exercise intervention on Mounjaro is resistance training — not cardiovascular exercise. This is because the primary risk of rapid weight loss is lean muscle loss, and resistance training is the most effective countermeasure. Aim for 2–3 sessions per week of weights, resistance bands, or bodyweight exercises (squats, lunges, push-ups, rows). Even modest resistance training produces significant lean mass preservation during Mounjaro treatment.

Exercise and dose escalation

Many patients find that each dose escalation is accompanied by temporarily reduced exercise tolerance due to nausea or fatigue. This is normal and temporary. Maintain light activity during the first week of each new dose. Return to your normal exercise routine as the new dose settles — typically within 7–10 days.

More Dosing Questions Answered

Average Weight Loss by Dose: The Full Data

Here is the complete efficacy picture by dose from the SURMOUNT programme — helping you understand what clinical outcomes to expect at each stage of your treatment and why escalation produces better results.

The dose-response relationship is clear and consistent: higher doses produce greater average weight loss and a higher proportion of patients achieving significant outcomes. The 5mg vs 15mg difference — 15% vs 22.5% — may seem modest in percentage terms, but represents meaningful absolute differences. For a patient starting at 100 kg, 15mg produces an average of 7.5 kg more weight loss than 5mg. For a patient starting at 150 kg, that difference grows to 11.3 kg.

The Clinical Science Behind the Schedule

Understanding why the Mounjaro dosing protocol works the way it does helps patients trust the process, particularly during the difficult first weeks of a new dose.

Pharmacokinetic basis for 4-week intervals

Tirzepatide has a half-life of approximately 5 days, meaning it takes approximately 4–5 half-lives (20–25 days, approximately 4 weeks) to reach steady-state plasma concentrations at a given dose. The 4-week minimum at each dose ensures that your body has reached stable, consistent drug levels before escalating. Escalating sooner would mean the next dose starts before the current one has even reached its full effect — producing unpredictable pharmacodynamics and worse side effects.

The GLP-1/GIP receptor adaptation mechanism

GLP-1 and GIP receptors partially downregulate (reduce their sensitivity) in response to sustained agonist exposure. This receptor adaptation is why side effects reduce significantly over the 4 weeks at each dose — the receptors have adjusted their response to the new drug level. When the dose is increased, the newly elevated drug level stimulates the receptors beyond their adapted threshold — producing a brief re-emergence of side effects until adaptation occurs again at the new level.

This mechanism explains why each dose escalation produces a brief return of nausea (typically shorter and milder than the previous escalation) — and why the brief discomfort is a sign that the new dose level is pharmacologically active, not a sign that the medication does not suit you.

Why the 2.5mg starting dose produces minimal weight loss

The 2.5mg dose was specifically designed for tolerability, not efficacy. At 2.5mg, tirzepatide occupies GLP-1 and GIP receptors at a sub-therapeutic level — enough to begin the adaptation process without producing the full appetite suppression and metabolic effects of therapeutic doses. Clinical trial data shows very modest weight loss at 2.5mg as a standalone dose. Its purpose is purely as an on-ramp to the therapeutic doses that follow.

Ordering Mounjaro at Slinic: Timing Your Monthly Order

To avoid gaps in treatment, it is important to order your next Mounjaro pen before your current one runs out. Here is the optimal ordering workflow at Slinic.

Slinic dispatches within 24 hours of approval with next-day cold-chain delivery in most areas. However, ordering early is always the safest approach — a 1–2 day gap in a weekly medication is clinically minor, but a 7+ day gap requires a conversation about whether to restart the dose protocol. See our restart guide for full detail on gaps in treatment.

Your Monthly Reorder Checklist

Before each monthly Slinic reorder, run through this quick checklist to ensure your dose management is on track:

• How many weeks at current dose? Minimum 4 before escalating
• How were side effects this month? If significant, discuss before escalating
• Is weight loss continuing or has it plateaued? Plateau after 4+ weeks signals escalation time
• Are you eating enough protein? Target 1.2-1.6g/kg target body weight
• Are you eating enough overall? Minimum 1,200 calories per day
• Any new medications or health changes? Relevant to monthly check-in

Your Slinic monthly check-in reviews all of these before approving your next dose. For the complete cost breakdown of your treatment journey, see our Mounjaro price guide.

Wegovy Dosing Schedule vs Mounjaro: Full Comparison

Mounjaro has 6 dose escalation steps to maximum (5 months); Wegovy has 4 to standard maintenance (4 months). Mounjaro consistently costs more per pen but produces higher average weight loss. Wegovy’s 7.2mg step-up dose was MHRA approved January 2026 and narrows the efficacy gap to approximately 1.8 percentage points. See our Mounjaro vs Wegovy guide for the full comparison.

The Mounjaro Dosing Schedule: Quick Reference Summary

For patients who want the key facts without reading the full guide:

• 6 doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
• Once weekly injection: Same day each week, any time of day
• Minimum 4 weeks at each dose before escalating
• 2.5mg is an initiation dose — not a therapeutic weight loss dose
• 5mg is the first therapeutic dose — significant appetite suppression begins here
• 10mg produces 19.5% average weight loss — many patients maintain here
• 15mg produces 22.5% average weight loss — maximum dose, measured at 72 weeks
• Side effects peak in week 1 of each new dose, then reduce. This is expected, normal, and temporary.
• If you miss a dose: take within 4 days, or skip and resume normal schedule
• If away more than 4 weeks: restart at 2.5mg
• Every Slinic escalation is clinically reviewed before dispatch

Practical Tips From 25 Years of Clinical Experience

As someone who reviews Mounjaro dose escalations every day at Slinic, here are the practical insights I wish every patient had before they started.

1. Inject at the same time on your chosen day

While Mounjaro does not need to be injected at the exact same time each week, consistency helps you remember. Many patients attach injection day to an existing weekly routine — Sunday morning, Friday evening, Tuesday lunchtime. Find an anchor and stick to it.

2. Keep a simple progress diary

Note your weight each week on the same day, before eating. Note any side effects. This gives you objective data for your monthly check-in and makes patterns clear — including if you are under-eating, experiencing unexplained side effects, or plateauing at a dose that might warrant escalation discussion.

3. Don’t compare your progress to social media

Social media Mounjaro before-and-after content is heavily self-selected — patients who achieve extraordinary results quickly are far more likely to post than those progressing steadily within the clinical average. The SURMOUNT-1 average of 22.5% at 72 weeks is derived from 2,539 patients — a far more reliable benchmark than the curated posts you see online.

4. Use your monthly check-in as a two-way clinical conversation

Slinic’s monthly check-in is not just an administrative approval step — it is a clinical consultation. Come with questions. Raise concerns. Ask about your diet, your protein intake, your side effect pattern. The prescriber reviewing your case has clinical experience of hundreds of Mounjaro patients and can provide personalised guidance that goes far beyond just approving your next dose.

5. Be patient with slow months

Weight loss on Mounjaro is not linear. Months of slower progress are normal — often reflecting fluid retention changes, hormonal fluctuations, or plateaus that precede a period of faster loss. A slow month at 7.5mg does not mean the medication is not working. It means you are building toward the sustained loss that produces the results SURMOUNT-1 documented over 72 weeks. Consistency and clinical support — not frustration-driven stopping — produce the best outcomes.

The dosing schedule is the structure. The clinical support is what makes the difference. Every Slinic patient gets both — a clinically reviewed escalation protocol and a prescriber who knows their history at every monthly check-in. Start your free eligibility assessment at slinic.co.uk.

References

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
2. Electronic Medicines Compendium. Mounjaro KwikPen Summary of Product Characteristics. 2026.
3. MHRA Drug Safety Update. Tirzepatide. January 2025. gov.uk
4. NICE TA1026 — Tirzepatide for managing overweight and obesity. 2025.

Related Guides